Thiazide-Associated Hyponatremia: A Population-Based Study Eline M. Rodenburg, MD, Ewout J. Hoorn, MD, PhD, Rikje Ruiter, MD, PhD, Jan J. Lous, MSc, Albert Hofman, MD, PhD, André G. Uitterlinden, PhD, Bruno H. Stricker, PhD, Loes E. Visser, PharmD, PhD  American Journal of Kidney Diseases  Volume 62, Issue 1, Pages 67-72 (July 2013) DOI: 10.1053/j.ajkd.2013.02.365 Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Study design; risk of hyponatremia in those using thiazides versus those not using thiazides, assessed in a case and at the same time of follow-up in the rest of the cohort, after which the case is censored. Participants in the Rotterdam Study (RS) from the 3 cohorts were included (RSI, RSII, and RSIII). Thiazide exposure is illustrated by the dotted vertical lines and cases are illustrated by an arrow. American Journal of Kidney Diseases 2013 62, 67-72DOI: (10.1053/j.ajkd.2013.02.365) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions